1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and oxidopamine

1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline has been researched along with oxidopamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, K; Horiguchi, Y; Hoshi, K; Katagiri, N; Kitabatake, M; Taguchi, K; Utsunomiya, I	1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and oxidopamine

Article	Year
Single administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline increases the extracellular concentration of dopamine in rat striatum. Neuroscience, 2009, Jun-02, Volume: 160, Issue:4 Topics: Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Extracellular Fluid; Male; Microdialysis; Motor Activity; Neurons; Oxidopamine; Rats; Rats, Wistar; Sodium Channel Blockers; Substantia Nigra; Sympatholytics; Tetrahydroisoquinolines; Tetrodotoxin	2009

Article

Year

Single administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline increases the extracellular concentration of dopamine in rat striatum.

Neuroscience, 2009, Jun-02, Volume: 160, Issue:4

Topics: Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Extracellular Fluid; Male; Microdialysis; Motor Activity; Neurons; Oxidopamine; Rats; Rats, Wistar; Sodium Channel Blockers; Substantia Nigra; Sympatholytics; Tetrahydroisoquinolines; Tetrodotoxin

2009